All Type of News
Jeil Pharm, Takeda Korea sign distribution agreement for Dexilant
Jeil Pharmaceutical Wednesday signed a distribution agreement with Takeda Korea to sell Takeda’s new proton-pump inhibitor Dexilant (dexlansoprazole) in Korea.
The launching ceremony was held at the Park Hyatt Hote...
Hanmi’s diabetic drugs featured in 2012 American Diabetes Association Meeting
Hanmi Pharmaceutical Co. said Wednesday that the clinical utility of the Company’s LAPSCOVERY-based lead diabetic drugs, LAPS-Exendin4 and LAPS-Insulin, was featured at the Annual Scientific Sessions of the American D...
Kang Moon-seok arrested for embezzlement
Kang Moon-seok, the second son of Dong-A Pharmaceutical Chairman Kang Shin-ho, was arrested Wednesday by prosecutors on charges of embezzlement and stealing bank funds.
Moon-seok, vice chairman of foreign wine and ...
Contribution of incumbent president
President Lee Myung-bak has contributed much to eradication of illegal rebate practice in domestic pharmaceutical industry as one of his achievements while he has been in office for four years, Cheong Wa Daesaid recen...
Innovative pharmaceutical firms selection triggers debate
Companies that failed to win a certification for innovative pharmaceutical firms are complaining about the selection criteria.
The Ministry of Health and Welfare Monday announced 43 successful candidates for the fi...
Doctors under fire over DRG system
The medical circle is under fire after the Korean Medical Association refuted the government’s argument Monday, saying that enforcing a new payment system based on diagnosis-related groups, or DRG, will deteriorate th...
Yuhan to introduce 7 original drugs
To prepare for government-mandated cuts in drug prices, Yuhan Corp. has recently unveiled its plan to sell seven original brands, including Boehringer Ingelhheim’s Micardis and Gilead’s Truvada, within the year by joi...
Supreme Court reaffirms optional treatment is uninsured, Health Ministry says
The Supreme Court set an exceptional ruling Monday to allow new medical treatments that have not yet been approved by the national health insurance and thus won’t cover the costs
In its ruling, the court stated tha...
43 drug makers selected as innovative pharmaceutical firms
The Ministry of Health and Welfare announced Monday a list of 43 innovative pharmaceutical firms that post more than 100 billion won in sales and invest at least 5 percent of their revenue in research and development ...
Selection criteria of innovative pharmaceutical firms questioned
The Ministry of Health and Welfare is accused of its ambiguous selection criteria for 43 innovative pharmaceutical firms, inviting criticism from domestic drug makers.
The accusation comes at a time when the minist...
